Stock GSK GLAXOSMITHKLINE PLC
Add to a list
To use this feature you must be a member
Log inSign up

Calendar GlaxoSmithKline plc LIQUIDNET SYSTEMS

Equities

GSK

GB0009252882

Delayed LIQUIDNET SYSTEMS
Other stock markets
 		5-day change 1st Jan Change
- EUR -.--% Intraday chart for GlaxoSmithKline plc -0.40% -.--%
06-01 Delaware judge lets more than 70,000 Zantac lawsuits go forward RE
06-01 GSK Regarding Ruling By Delaware State Court On Zantac Litigation Will Immediately Seek Appeal RE

Chart calendar GlaxoSmithKline plc

e8dc0bc57a9ca6c908a06f28f.WCQL9cMnOcxzJd9O2vE8umC3sYpDRAe7fKpwHoc39WU.DWpluYgfAYtKRpsW6b5XiBLcwacOfV3oFdkeUOVvpz01UGy8jVR6tClh6w~3cf710f648474706843a38e9e3480f0b

Upcoming events on GlaxoSmithKline plc

05/06/2024 BNP Paribas Exane CEO Conference
31/07/2024 07:00 Q2 2024 Earnings Release
30/10/2024 06:00 Q3 2024 Earnings Release
05/02/2025 07:00 Q4 2024 Earnings Release
29/04/2025 Q1 2025 Earnings Release (Projected)
22/07/2025 Q2 2025 Earnings Release (Projected)
28/10/2025 Q3 2025 Earnings Release (Projected)
10/02/2026 Q4 2025 Earnings Release (Projected)

Past events on GlaxoSmithKline plc

30/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #8627
30/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #LBA3512
30/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #8017
30/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #7530
30/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #TPS5627
30/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #e19523
30/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #TPS6125
30/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #e19532
30/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #e19524
30/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #e19507
30/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #e19503
30/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #7559
30/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #e23110
30/05/2024 American Society of Clinical Oncology Meeting - MV. Mateos
30/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #7503
30/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #7543
30/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #5606
30/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #5607
30/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #TPS3174
30/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #e23106

Past dividends on GlaxoSmithKline plc

15/05/2024 Interim Payment 0.15 GBP
21/02/2024 Final Payment 0.16 GBP
15/11/2023 Interim Payment 0.14 GBP
16/08/2023 Interim Payment 0.14 GBP
17/05/2023 Interim Payment 0.14 GBP
22/02/2023 Final Payment 0.1375 GBP
16/11/2022 Interim Payment 0.1375 GBP
17/08/2022 Interim Payment 0.1625 GBP
17/07/2022 0 GBP
18/05/2022 Interim Payment 0.14 GBP

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million GBP		Released
Forecast
Spread 		33 754
33 382
1.11%		34 099
34 076
0.07%		34 114
34 029
0.25%		29 324
29 105
0.75%		30 328
29 850
1.6%
31 636

EBITDA
Million GBP		Released
Forecast
Spread 		11 968
11 155
7.28%		9 530
10 575
-9.88%		11 330
10 048
12.76%		10 449
9 257
12.88%		11 635
10 203
14.04%
10 568

EBIT
Million GBP		Released
Forecast
Spread 		8 972
9 182
-2.29%		8 906
8 955
-0.55%		8 806
8 717
1.02%		8 151
7 952
2.5%		8 786
8 780
0.07%
9 179

Earnings before Tax (EBT)
Million GBP		Released
Forecast
Spread 		6 221
5 926
4.97%		6 968
6 763
3.02%		5 442
5 794
-6.07%		5 628
5 548
1.45%		6 064
7 498
-19.12%
7 386

Net income
Million GBP		Released
Forecast
Spread 		4 645
4 026
15.38%		5 749
4 894
17.46%		4 385
3 990
9.91%		14 956
6 238
139.74%		4 928
5 481
-10.09%
5 555

EPS
GBP		Released
Forecast
Spread 		1,16
1,06
9.69%		1,43
1,21
17.91%		1,08
1,02
6.28%		3,66
1,66
120.52%		1,22
1,38
-11.61%
1,37

Announcement Date05/02/2003/02/2109/02/2201/02/2331/01/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million GBP		Released
Forecast
Spread 		9 780
9 145
6.94%		6 929
6 906
0.33%		7 829
7 214
8.52%		7 376
7 101
3.88%		6 951
6 580
5.64%		7 178
6 795
5.63%		8 147
7 727
5.43%		8 052
7 621
5.65%		7 363
7 060
4.3%
7 533


8 534


8 219


7 590


7 865

EBITDA
Million GBP		Released
Forecast
Spread 		3 317
2 850
16.4%		2 639
2 138
23.45%		3 561
2 704
31.68%		1 602
1 855
-13.63%		2 732
2 418
12.97%		2 622
2 506
4.64%		3 351
3 072
9.09%		2 930
2 094
39.93%		2 992
2 406
24.36%
2 594


3 095


1 835







EBIT
Million GBP		Released
Forecast
Spread 		2 613
2 291
14.06%		2 008
1 740
15.4%		2 605
2 264
15.08%		1 595
1 509
5.7%		2 092
1 930
8.42%		2 170
1 999
8.56%		2 772
2 570
7.88%		1 752
1 836
-4.58%		2 443
2 099
16.38%
2 216


2 793


1 757


2 408


2 487

Earnings before Tax (EBT)
Million GBP		Released
Forecast
Spread 		2 598
2 268
14.55%		896
1 243
-27.89%		1 012
1 860
-45.59%		1 626
946
71.97%		1 907
1 529
24.72%		1 987
1 500
32.51%		1 791
2 225
-19.51%		379
1 361
-72.15%		1 355
1 696
-20.11%
1 823


2 493


1 317







Net income
Million GBP		Released
Forecast
Spread 		1 802
1 674
7.66%		975
802
21.54%		10 315
1 356
660.76%		1 495
1 151
29.9%		1 490
1 179
26.41%		1 624
1 213
33.86%		1 464
1 739
-15.79%		350
834
-58.04%		1 046
1 297
-19.32%
1 425


1 877


1 214







EPS
GBP		Released
Forecast
Spread 		0,45
0,41
8.83%		0,21
0,21
-3.22%		2,52
0,34
640.73%		0,37
0,19
95.19%		0,37
0,29
27.52%		0,40
0,30
35.52%		0,36
0,43
-15.26%		0,09
0,20
-58.02%		0,25
0,31
-19.17%
0,35


0,46


0,23







Announcement Date27/04/2227/07/2202/11/2201/02/2326/04/2326/07/2301/11/2331/01/2401/05/24-----

Upcoming sector events for GlaxoSmithKline plc

03/07/2024 HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected)
10/07/2024 HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release (Projected)
15/07/2024 JOHNSON & JOHNSON: Q2 2024 Earnings Release (Projected)
15/07/2024 CAMURUS AB: Q2 2024 Earnings Release
16/07/2024 GLAND PHARMA LIMITED: Q1 2025 Earnings Release (Projected)
17/07/2024 JUBILANT PHARMOVA LIMITED: Q1 2025 Earnings Release (Projected)
18/07/2024 06:00 NOVARTIS AG: Q2 2024 Earnings Release
21/07/2024 GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected)
21/07/2024 ALMIRALL, S.A.: Q2 2024 Earnings Release
22/07/2024 TORRENT PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected)
More events

Past sector events for GlaxoSmithKline plc

30/05/2024 13:08 SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release
30/05/2024 12:00 ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release
30/05/2024 07:24 MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release
29/05/2024 13:00 FDC LIMITED: Q4 2024 Earnings Release
29/05/2024 10:26 JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release
29/05/2024 09:44 ALKEM LABORATORIES LIMITED: Q4 2024 Earnings Release
29/05/2024 09:10 IPCA LABORATORIES LIMITED: Q4 2024 Earnings Release
28/05/2024 PFIZER LIMITED: Q4 2024 Earnings Release
27/05/2024 DOTTIKON ES HOLDING AG: Q4 2024 Earnings Release
27/05/2024 13:10 ASTRAZENECA PHARMA INDIA LIMITED: Q4 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. GSK Stock
  4. GSK Stock
  5. Calendar GlaxoSmithKline plc